Your browser doesn't support javascript.
loading
Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma.
Chen, Shuyu; Chen, Zhuoyu; Deng, Yao; Zha, Shanshan; Yu, Li; Li, Difei; Liang, Zhenyu; Yang, Kai; Liu, Shengming; Chen, Rongchang.
Afiliação
  • Chen S; Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), The First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People's Hospital), Shenzhen, C
  • Chen Z; Department of Clinical Laboratory, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, China.
  • Deng Y; Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), The First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People's Hospital), Shenzhen, C
  • Zha S; Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), The First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People's Hospital), Shenzhen, C
  • Yu L; Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), The First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People's Hospital), Shenzhen, C
  • Li D; Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), The First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People's Hospital), Shenzhen, C
  • Liang Z; The First Affiliated Hospital, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.
  • Yang K; Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), The First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People's Hospital), Shenzhen, C
  • Liu S; Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Jinan University, Guangzhou, China. Electronic address: tlsm@jnu.edu.cn.
  • Chen R; Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), The First Affiliated Hospital of Southern University of Science and Technology (Shenzhen People's Hospital), Shenzhen, C
Allergol Int ; 71(1): 73-82, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34332882
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Interleucina-6 / Anticorpos Monoclonais Humanizados Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Interleucina-6 / Anticorpos Monoclonais Humanizados Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article